
dehaze enables clinicians to harness the power of AI for precise diagnostics and prognostics, aiming to tailor every patient's diagnosis and treatment to their unique health data. The company is driven by a vision to move beyond standardized guidelines in healthcare, leveraging advanced AI technology to improve patient outcomes. With a team of experienced professionals, including a serial entrepreneur and leading researchers in biomedical AI, dehaze is positioned to make a significant impact in the healthcare sector, focusing on precision medicine and innovative solutions.

dehaze enables clinicians to harness the power of AI for precise diagnostics and prognostics, aiming to tailor every patient's diagnosis and treatment to their unique health data. The company is driven by a vision to move beyond standardized guidelines in healthcare, leveraging advanced AI technology to improve patient outcomes. With a team of experienced professionals, including a serial entrepreneur and leading researchers in biomedical AI, dehaze is positioned to make a significant impact in the healthcare sector, focusing on precision medicine and innovative solutions.
Sector: Healthcare AI / Healthtech
Headcount: 9 employees
Product: AI health intelligence platform (AI copilot for clinicians)
Scale metrics: 250k+ patient lives analyzed; 300M health events; 200+ AI algorithms
Notable partner/investor: Techstars
Clinical decision support and precision medicine (identifying missed diagnoses, inappropriate treatments, and predicting future health risks).
Healthtech / Healthcare AI
Crunchbase lists a Pre-Seed round with Techstars as lead; dehaze's site displays Techstars among partners/affiliations.
“Techstars listed as lead/pre-seed investor and partner”